The induction of metabolizing enzymes by PXR can lead to significant drug-drug interactions. For example, the co-administration of drugs that activate PXR can increase the metabolism of co-administered medications, potentially reducing their efficacy. Understanding these interactions is critical for developing safe pharmacological therapies and avoiding adverse effects.
